SEBASTIANI, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.144
EU - Europa 20.011
AS - Asia 3.979
SA - Sud America 178
OC - Oceania 92
AF - Africa 85
Continente sconosciuto - Info sul continente non disponibili 24
Totale 44.513
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.907
IT - Italia 11.839
GB - Regno Unito 3.434
SG - Singapore 1.204
SE - Svezia 1.190
CN - Cina 1.121
DE - Germania 714
UA - Ucraina 588
FR - Francia 560
HK - Hong Kong 449
TR - Turchia 420
FI - Finlandia 398
RU - Federazione Russa 323
BG - Bulgaria 240
ID - Indonesia 184
JP - Giappone 149
IN - India 148
NL - Olanda 145
IE - Irlanda 134
CA - Canada 116
MX - Messico 85
AU - Australia 82
CH - Svizzera 73
PL - Polonia 60
VN - Vietnam 60
BR - Brasile 57
LT - Lituania 53
BE - Belgio 48
KR - Corea 45
RO - Romania 45
AR - Argentina 41
PK - Pakistan 39
ES - Italia 38
MY - Malesia 34
TN - Tunisia 32
BZ - Belize 31
IR - Iran 31
CL - Cile 26
CO - Colombia 21
EU - Europa 21
PT - Portogallo 19
EG - Egitto 18
TW - Taiwan 18
HU - Ungheria 17
SA - Arabia Saudita 16
AT - Austria 15
GR - Grecia 15
PH - Filippine 14
CZ - Repubblica Ceca 13
PE - Perù 13
EC - Ecuador 11
ZA - Sudafrica 11
DK - Danimarca 10
NZ - Nuova Zelanda 10
LU - Lussemburgo 8
IL - Israele 7
IQ - Iraq 7
JO - Giordania 6
MA - Marocco 6
NO - Norvegia 6
RS - Serbia 6
TH - Thailandia 6
DZ - Algeria 5
KE - Kenya 5
BO - Bolivia 4
LB - Libano 4
VE - Venezuela 4
HR - Croazia 3
AL - Albania 2
AM - Armenia 2
AZ - Azerbaigian 2
BD - Bangladesh 2
BY - Bielorussia 2
GT - Guatemala 2
IS - Islanda 2
LK - Sri Lanka 2
LV - Lettonia 2
MD - Moldavia 2
MK - Macedonia 2
NG - Nigeria 2
NP - Nepal 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
UG - Uganda 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AP - ???statistics.table.value.countryCode.AP??? 1
CR - Costa Rica 1
CY - Cipro 1
ET - Etiopia 1
GH - Ghana 1
HN - Honduras 1
KG - Kirghizistan 1
KZ - Kazakistan 1
MM - Myanmar 1
MN - Mongolia 1
MZ - Mozambico 1
PA - Panama 1
QA - Qatar 1
SC - Seychelles 1
Totale 44.510
Salva come PNG Salva come JPEG
Città #
Southend 2.843
Santa Clara 2.830
Fairfield 2.496
Chandler 1.403
Woodbridge 1.390
Ashburn 1.242
Houston 1.120
Singapore 979
Jacksonville 942
Milan 887
Seattle 873
Wilmington 827
Ann Arbor 783
Cambridge 781
Rome 781
Nyköping 687
Dearborn 669
Hong Kong 427
Modena 343
Beijing 297
San Diego 257
Helsinki 238
Izmir 237
Princeton 234
Sofia 232
Bologna 202
Florence 198
New York 195
Redwood City 189
Eugene 182
Jakarta 177
Turin 176
Naples 174
Bari 155
Palermo 144
London 134
Des Moines 130
Moscow 130
Genoa 113
Bremen 111
Catania 101
Falls Church 91
Cagliari 88
Dublin 86
Padova 86
Verona 86
Shanghai 84
Los Angeles 72
Boardman 70
Brescia 61
San Jose 56
Parma 54
Frankfurt am Main 52
Tokyo 49
Perth 46
Norwalk 44
Monza 43
Salerno 43
Bergamo 41
Guangzhou 40
Chicago 38
Dong Ket 38
Brussels 36
Munich 36
Torino 35
Messina 34
Toronto 34
Trento 32
Belize City 31
Pisa 31
Nanjing 30
Pescara 30
Trieste 30
Kunming 29
Venice 29
Atlanta 28
Hounslow 28
Livorno 28
Reggio Emilia 28
Ancona 26
Ottawa 26
Perugia 26
Dallas 25
Novara 25
Rimini 25
Lappeenranta 24
Napoli 24
Oristano 24
Hefei 23
Mumbai 23
Amsterdam 22
Caserta 22
Kilburn 22
Treviso 22
Jinan 21
Mountain View 21
São Paulo 21
Reggio Calabria 20
Reggio Nell'emilia 20
Paris 19
Totale 28.587
Salva come PNG Salva come JPEG
Nome #
Prevalenza delle epatiti nelle malattie reumatiche 5.450
INTERSTIZIOPATIA POLMONARE NON CLASSIFICABILE O SECONDARIA A CONNETTIVITE INDIFFERENZIATA. IMPORTANZA E DIFFICOLTÀ DI UNA DIAGNOSI DIFFERENZIALE. 3.202
TIPIZZAZIONE CLINICA DELLA SINDROME ANTISINTETASICA: CONFRONTO TRA PAZIENTI ANTI JO-1 POSITIVI E NEGATIVI 1.083
Epidemiology and management of interstitial lung disease in ANCA-associated vasculitis 988
HCV-unrelated cryoglobulinaemic vasculitis: the results of a prospective observational study by the Italian Group for the Study of Cryoglobulinaemias (GISC) 690
ALTERAZIONI CAPILLAROSCOPICHE IN CORSO DI DERMATOMIOSITE E SCLEROSI SISTEMICA; VERSO L’INDIVIDUAZIONE DI PATTERN SPECIFICI 667
La capillaroscopia in reumatologia. Lesioni elementari e metodi di scoring 391
Semeiotica dell'articolazione temporo-mandibolare 390
Capillaroscopia del letto periungueale in pazienti affetti da artrite psoriasica e spondilite anchilosante. 301
Evoluzione dello CSURI (Capillaroscopic Skin Ulcer Risk Index) in pazienti affetti da sclerosi sistemica in terapia con antiendotelina-1 e prostanoidi 300
Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: The InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device) 289
Recommendations for the management of pulmonary fungal infections in patients with rheumatoid arthritis 275
Analysis of pulmonary sounds for the diagnosis of interstitial lung diseases secondary to rheumatoid arthritis 274
Radiologic classification of usual interstitial pneumonia in rheumatoid arthritis-related interstitial lung disease: correlations with clinical, serological and demographic features of disease 259
Efficacia di terapia con immunoassorbimento con proteina A dello stafilococco e talidomide in un caso di dermatomiosite refrattaria. 248
Current treatment of hepatitis C-associated rheumatic diseases. 242
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register 242
Elevated Troponin Serum Levels in Adult Onset Still's Disease 242
Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline 236
Cryoglobulinemic vasculitis and skin ulcers. Our therapeutic strategy and review of the literature 236
Combination Therapy with Nintedanib and Sarilumab for the Management of Rheumatoid Arthritis Related Interstitial Lung Disease 232
Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature 229
Carotidynia Possibly due to Localized Vasculitis in a Patient with Latent Mycobacterium tuberculosis Infection. 228
NEW PERSPECTIVES IN DIAGNOSIS OF INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. VALIDATION STUDY OF AN ELECTRONIC STETHOSCOPE AND AD HOC SOFTWARE FOR DETECTION OF PULMONARY CRACKLES 223
Aortic pulse wave velocity measurement in systemic sclerosis patients. 217
Chemokines in the pathogenesis and as therapeutical markers and targets of HCV chronic infection, and HCV extrahepatic manifestations 215
Cardiac Involvement in Systemic Vasculitis 213
Nailfold capillaroscopic changes in dermatomyositis and polymyositis 213
Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients. 209
Polymyositis following Pandemic Influenza A (H1N1) and 2009-10 Seasonal Trivalent Vaccines 205
Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature 205
Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications 203
Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature. 203
Unusual association between Budd–Chiari syndrome secondary to antiphospholipid syndrome and relapsing polychondritis: a case report and review of the literature 201
New targeted molecular therapies for dedifferentiated thyroid cancer 198
Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients' population and review of the literature 197
Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature 197
HCV-related rheumatic manifestations and therapeutic strategies 196
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitis. 195
Timing of onset affects arthritis presentation pattern in antisyntethase syndrome 194
Validation of the classification criteria for cryoglobulinaemic vasculitis 193
B-cells and mixed cryoglobulinemia 193
Nailfold Videocapillaroscopy Alterations in Dermatomyositis and Systemic Sclerosis: Toward Identification of a Specific Pattern 191
Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicenter retrospective study 191
Effect of treatment with iloprost with or without bosentan on nailfold videocapillaroscopic alterations in patients with systemic sclerosis 190
Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement 190
International diagnostic guidelines for patients with HCV-related extrahepatic manifestations. A multidisciplinary expert statement 183
EFFICACIA, SAFETY E TOLLERANZA DI ADALIMUMAB IN PRIMA E SECONDA LINEA IN PAZIENTI CON ARTRITE REUMATOIDE: ESPERIENZA DAI REGISTRI ITALIANI DEI FARMACI BIOLOGICI 182
Epstein-barr virus reactivation after infliximab in rheumatoid arthritis: a case report. 181
Micro and nanoparticles as possible pathogenetic co-factors in mixed cryoglobulinemia 181
Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis 180
Nailfold Capillaroscopy Characteristics of Antisynthetase Syndrome and Possible Clinical Associations: Results of a Multicenter International Study 179
Retreatment regimen of rituximab monotherapy given at the relapse of severe HCV-related cryoglobulinemic vasculitis: Long-term follow up data of a randomized controlled multicentre study 179
THU0366 Gastrointestinal infections in patients with spondyloarthritis treated with anti-tnf drugs: results of gisea register 178
Measuring microangiopathy abnormalities in systemic sclerosis patients: the role of capillaroscopy-based scoring models 176
HRCT Patterns Of Usual Interstitial Pneumonia In Rheumatoid Lung 176
Heart involvement and systemic sclerosis 175
The Expanding Spectrum of Clinical Features in HCV-Related Mixed Cryoglobulinemia 175
D-penicillamine in the treatment of eosinophilic fasciitis: case reports and review of the literature. 175
Capillaroscopic Skin Ulcers Risk Index (CSURI) calculated with different videocapillaroscopy devices: how its predictive values change 175
Mixed cryoglobulinemia: Demographic, clinical, and serologic features and survival in 231 patients 175
INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. WHAT DO WE DON’T KNOW? THE LIRA STUDY (LUNG INVOLVEMENT IN RHEUMATOID ARTHRITIS) 175
Prediction risk chart for scleroderma digital ulcers: A composite predictive model based on capillaroscopic, demographic and clinico-serological parameters 174
Treatment of HCV-related mixed cryoglobulinemia 174
The profiling of axial spondyloarthritis patient candidate to a biologic therapy: Consensus from a Delphi-panel of Italian experts 174
Phantom Limb Pain in Patients with Severe Cryoglobulinemic Vasculitis: Usefulness of Long-Term Pregabalin Treatment 173
Thymus alterations and systemic sclerosis 173
UNCLASSIFIABLE INTERSTITIAL LUNG DISEASE OR UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE? A CHALLENGING DIFFERENTIAL DIAGNOSIS 173
High values of CXCL10 serum levels in mixed cryoglobulinemia associated with hepatitis C infection 173
Diagnosis and treatment of rheumatoid arthritis in the Emilia Romagna region: a prospective population-based study 172
Hepatitis C virus syndrome: A constellation of organ- and non-organ specific autoimmune disorders, B-cell non-Hodgkin's lymphoma, and cancer 171
Parallel increase of circulating CXCL11 and CXCL10 in mixed cryoglobulinemia, while the proinflammatory cytokine IL-6 is associated with high serum Th2 chemokine CCL2 169
Factors Predicting Early Failure of Etanercept in Rheumatoid Arthritis: An Analysis From the Gruppo Italiano di Studio sulla Early Arthritis (Italian Group for the Study of Early Arthritis) Registry 168
Neurologic Complications Associated with Sjögren's Disease: Case Reports and Modern Pathogenic Dilemma 167
Systemic sclerosis following human cytomegalovirus infection 166
Correlation of a quantitative videocapillaroscopic score with the development of digital skin ulcers in scleroderma patients 166
Virus-driven autoimmunity and lymphoproliferation: the example of HCV infection 166
The performance of the GAP model in patients with rheumatoid arthritis associated interstitial lung disease 166
Autologous skin grafting in the treatment of severe scleroderma cutaneous ulcers: a case report 165
Scleroderma Digital Ulcers Complicated by Infection with Fecal Pathogens. 165
CORRELATION OF A QUANTITATIVE VIDEOCAPILLAROSCOPIC SCORE WITH THE DEVELOPMENT OF DIGITAL SKIN ULCERS IN SCLERODERMA PATIENTS 164
Procedural pain management in the treatment of scleroderma digital ulcers 163
L-Arginine in pregnant scleroderma patients 163
Treatment of severe scleroderma skin ulcers with recombinant human erythropoietin 161
AB1157 VALIDATION OF VECTOR (VELCRO CRACKLES DETECTOR) FOR THE DIAGNOSIS OF INTERSTITIAL LUNG DISEASE IN PATIENTS WITH CONNECTIVE TISSUE DISEASES 161
HCV-related autoimmune and neoplastic disorders: the HCV syndrome 160
Nailfold videocapillaroscopy in antisynthetase syndrome 160
High values of CXCL10 serum levels in patients with hepatitis C associated mixed cryoglobulinemia in presence or absence of autoimmune thyroiditis 159
Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: results of multicenter cohort study and review of the literature. 159
Validation study of predictive value of capillaroscopic skin ulcer risk index (CSURI) in scleroderma patients treated with bosentan 159
Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study 159
Tocilizumab for the treatment of patients with rheumatoid arthritis and interstitial lung diseases: a case series 158
Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment: routine care data from 13 registries in the EuroSpA collaboration 158
Drug survival of adalimumab in patients with rheumatoid arthritis over 10 years in the real-world settings: high rate remission together with normal function ability 157
COST ANALYSIS RELATED TO SUBCUTANEOUS IMMUNOGLOBULINS IN PATIENTS WITH INFLAMMATORY MYOPATHIES AND IMMUNE-MEDIATED CHRONIC NEUROPATHIES. RESULTS OF AN OPEN LABEL STUDY 157
IFN-γ and TNF-α induce a different modulation of interleukin-6 in systemic sclerosis fibroblasts compared to healthy controls. 155
High rate of disease remission in moderate rheumatoid arthritis on etanercept therapy: data from GISEA, the Italian biologics register 155
Circulating CXCL11 and CXCL10 are increased in hepatitis C-associated cryoglobulinemia in the presence of autoimmune thyroiditis. 154
Cardiovascular risk and prostanoids in systemic sclerosis 153
Interstitial pneumonia with autoimmune features: A single center prospective follow-up study 153
Totale 30.394
Salva come PNG Salva come JPEG
Categoria #
all - tutte 181.053
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 181.053
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.222 0 0 0 0 0 967 870 756 634 317 389 289
2020/20216.435 527 274 482 656 614 552 593 795 400 645 426 471
2021/20225.162 278 415 377 408 239 423 271 312 585 472 748 634
2022/20237.737 676 522 436 487 804 957 523 753 945 354 745 535
2023/20247.596 470 503 547 790 1.025 553 653 868 294 485 599 809
2024/20256.633 705 370 449 972 2.413 1.724 0 0 0 0 0 0
Totale 45.155